论文部分内容阅读
杀菌剂按着保护、治疗、保护+治疗、植物健康的道路发展,与杀虫剂、除草剂相比,杀菌剂复合增长率将长期被看好,过亿美元的24种杀菌剂,占据市场份额61.83%。杀菌剂成为企业利润的主要来源,2016年也不断涌现千万级大单品。甲氧基丙烯酸酯类成为主要类别,其次是三唑类,琥珀酸脱氢酶抑制剂类(SDHI)增长速度很快,潜力巨大,这类产品主要是以复配为主,防治灰霉病、白粉病和叶斑病等。SDHI类产品中,吡噻菌胺,专利已到期;氟吡菌酰胺,2023年到期,未来有望成为线虫防
Fungicide According to the road of protection, treatment, protection + treatment and plant health, the compound growth rate of bactericide will be favored over a long period of time compared with pesticides and herbicides. Twenty-four billion fungicides with a market share of over billion dollars 61.83%. Bactericide has become the main source of corporate profits in 2016, there are also tens of millions of large-scale single product. Methoxy acrylates become the main category, followed by triazoles, succinate dehydrogenase inhibitors (SDHI) rapid growth, great potential, these products are mainly based on compound to control gray mold , Powdery mildew and leaf spot and so on. In the products of SDHI, penthiopyrad has been expired and the patent for fluopyram has expired in 2023 and is expected to become nematode defense